article · Zenodo (CERN European Organization for Nuclear Research)
Investment in tuberculosis research has led to the development of efficacious new treatments. Pragmatic trials are needed to evaluate the effectiveness of new treatments in real-life routine practice conditions and thereby appropriately inform practice guidelines and facilitate uptake. Leveraging the expertise of the FAST-TB (Facilitating Accelerated Science and Translation for TB Regimen Development) network, this review lays out a scientific framework and guiding principles for pragmatic TB trials.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.5281/zenodo.20229181
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.